KRAS and neoplasm: The percentages of plasma samples with mutated Ki-ras gene found to date in the existing studies differ in a wide range of 27–81%, which might reflect collection of samples at different tumour stages and various sensitivities of the assays for detection of Ki-ras point mutations.